Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Conduit Pharmaceuticals
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
August 12, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
August 08, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
July 16, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals to Join Russell 3000® Index
June 13, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
March 19, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
March 11, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 31, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
November 02, 2023
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
October 11, 2023
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination
September 22, 2023
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Tickers
CDT
MURF
SQFT
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.